Skip to content
Clinical Trials – home
United KingdomBack to the United Kingdom

Clinical trials in Grengegorman – page 22

334 clinical trials in Grengegorman, United Kingdom. Every trial is listed in the EU Clinical Trials Register and updated daily.

Grengegorman at a glance
334
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

334 trials in Grengegorman

Open in trial search

Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Incyte Corp.

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim Espana S.A.

Osteochondrodysplasia

Not recruiting

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA-1-ANTITRYPSIN
  • Sponsor:Sanofi AATD Inc.

Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Mavacamten
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

HIV infection+1

Not recruiting

Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:University College Dublin

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Iron deficiency anaemia+1

Not recruiting

Study on Daily vs. Alternate Day Iron Supplements for Treating Iron Deficiency Anemia in Pregnant Women

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Iron
  • Sponsor:University College Dublin

Uveal melanoma+2

Not recruiting

Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan
  • Sponsor:Aura Biosciences Inc.

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Ovarian cancer

Not recruiting

Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Brimonidine Tartrate
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Clinical research in Grengegorman

What the registry says about research in the country

01 Ophthalmology Research

Innovative clinical trials focusing on treating myopia progression in pediatric patients, exploring new therapeutic approaches for vision care management.

  • Pediatric Vision Care
  • Myopia Management
  • Visual Development

Research efforts aim to evaluate novel treatments for controlling childhood nearsightedness, potentially offering new solutions for young patients struggling with progressive vision changes.

02 Pediatric Eye Care

Dedicated studies examining the effectiveness of new ophthalmic solutions in managing vision disorders among children, with a focus on long-term treatment outcomes.

  • Vision Development
  • Early Intervention
  • Treatment Safety

These trials represent significant advances in pediatric ophthalmology, investigating safe and effective interventions for young patients with progressive vision conditions.

03 Vision Science

Comprehensive research into vision disorders affecting young populations, utilizing controlled clinical studies to advance understanding and treatment options.

  • Clinical Efficacy
  • Treatment Innovation
  • Long-term Outcomes

The studies emphasize the importance of early intervention and monitoring in pediatric vision care, with potential implications for future treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.